Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
319.3 USD | -0.85% | -1.71% | +12.79% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 32.24 and 26.36 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.31 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.79% | 26.4B | B- | ||
+51.85% | 57.87B | B- | ||
+41.42% | 40.25B | A | ||
-5.25% | 39.94B | B | ||
-5.16% | 28.54B | C | ||
-20.18% | 19.33B | B | ||
+30.88% | 12.4B | C+ | ||
+0.61% | 12.23B | B+ | ||
+25.06% | 12.2B | B+ | ||
-9.14% | 11.06B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ICLR Stock
- Ratings ICON Public Limited Company